Dr. Silva Markovic-Plese, MD

Dr. Markovic-Plese practices at Jefferson University Physicians in Philadelphia, Pennsylvania.

Dr. Markovic-Plese's NPI, 1255403747, was assigned on November 14, 2006. Dr. Markovic-Plese holds Pennsylvania license MD465884.

Dr. Markovic-Plese's primary practice is Jefferson University Physicians, at 909 Walnut St, Philadelphia, PA 19107 in Philadelphia County. The practice phone is (215) 955-0000.

Dr. Markovic-Plese's primary practice is Jefferson University Physicians in Philadelphia, Pennsylvania. Dr. Markovic-Plese is also affiliated with Thomas Jefferson University Hospital. The medical group on file is Jefferson University Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Markovic-Plese practices. Vendor and product names are available with a free account.

Neurological surgery is Dr. Markovic-Plese's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dmand AI has Dr. Markovic-Plese's licenses on file in 2 states: Pennsylvania and North Carolina.

CMS data shows 34 Medicare services from Dr. Markovic-Plese across 2 procedure codes in 2024, for 71 Medicare patients. Medicare paid $2,687 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 71 Medicare patients who saw Dr. Markovic-Plese in 2024. The largest group is 65 to 74, with 29 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 35% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Markovic-Plese's median patient age at 50, with 68% women.

In 2024, Dr. Markovic-Plese wrote 357 Medicare Part D claims for 43 patients. 88% of them were for generic drugs. CMS names the drug for 249 of them, across 12 drugs with 11 or more claims each, at $446,210 in total drug cost. In 2023, CMS named 167 claims across 10 drugs.

Dr. Markovic-Plese accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Markovic-Plese as offering telehealth.

Dmand AI links 32 papers to Dr. Markovic-Plese, published from 2005 to 2024. 2015 was the busiest year, with 4. The most frequent topics are Multiple Sclerosis, Relapsing-Remitting, CD4-Positive T-Lymphocytes and Multiple Sclerosis. Dr. Markovic-Plese has published most often in J Immunol. Dr. Markovic-Plese's most frequent co-authors are Fernando Dangond, MD, Valerie L. Jewells, MD and Mirela Cerghet, MD, PhD.

CMS Open Payments shows 72 general payments to Dr. Markovic-Plese from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 42% of the total. EMD Serono, Inc. paid the most, $28,006. It also lists 4 research payments totaling $46,266 in 2016.